Clinical Trials Browser

Phase 3 × Breast Neoplasms × Abiraterone Acetate × Clear all

NCT01517802 2022-05-10

A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

Phase 3 Completed

32 enrolled 7 charts

Breast Neoplasms